Cargando…
GSK‐3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα
Deregulation of GSK‐3β is strongly implicated in a variety of serious brain conditions, such as Alzheimer disease, bipolar disorder and schizophrenia. To understand how GSK‐3β becomes dysregulated in these conditions, it is important to understand its physiological functions in the central nervous s...
Autores principales: | Amici, Mascia, Lee, Yeseul, Pope, Robert J. P., Bradley, Clarrisa A., Cole, Adam, Collingridge, Graham L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554790/ https://www.ncbi.nlm.nih.gov/pubmed/32463939 http://dx.doi.org/10.1111/ejn.14841 |
Ejemplares similares
-
A pivotal role of GSK-3 in synaptic plasticity
por: Bradley, Clarrisa A., et al.
Publicado: (2012) -
The GSK-3 Inhibitor CT99021 Enhances the Acquisition of Spatial Learning and the Accuracy of Spatial Memory
por: Lee, Yeseul, et al.
Publicado: (2022) -
Specific Role for GSK3α in Limiting Long-Term Potentiation in CA1 Pyramidal Neurons of Adult Mouse Hippocampus
por: Ebrahim Amini, Aeen, et al.
Publicado: (2022) -
NMDAR‐dependent Argonaute 2 phosphorylation regulates miRNA activity and dendritic spine plasticity
por: Rajgor, Dipen, et al.
Publicado: (2018) -
The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)